OncoGenex Pharma (OGXI) Tops Q4 EPS by 4c

OncoGenex Pharma (NASDAQ: OGXI) reported Q4 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $5.7 million versus the consensus estimate of $4.3 million.

For earnings history and earnings-related data on OncoGenex Pharma (OGXI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c